Champion Healthcare LLC
Champion Healthcare LLC was paid $1.19M by Medicaid between Sep 2018 and Dec 2024, across 24 billing codes. Its largest line is H0016, Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) — 20% of everything it billed.
33Billing provider infoCHAMPION HEALTHCARE LLC
LEBANON, TN 37087
LEBANON, TN 37087
33aNPI1508262247assigned 11/06/2014
33bProvider typeContractor
28Total paid$1.19M
24GClaims31,918
24DCodes billed24
24AFirst – last monthSep 2018 – Dec 2024
Compared with peers
Next to other Contractor providers in Tennessee
Rank by total paid#1 of 7
Median peer was paid$440K
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 413 | $19K | |
| 2019 | 3,564 | $157K | |
| 2020 | 4,566 | $204K | |
| 2021 | 5,273 | $112K | |
| 2022 | 6,272 | $223K | |
| 2023 | 7,110 | $298K | |
| 2024incomplete | 4,720 | $175K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 20% | 1,719 | 1,057 | $238K |
| H0033 | Oral medication administration, direct observation | 18% | 2,578 | 1,571 | $211K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 6,216 | 3,517 | $188K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 12% | 3,786 | 2,448 | $142K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 8.0% | 4,246 | 2,471 | $95K |
| H2010 | Comprehensive medication services, per 15 minutes | 6.7% | 1,198 | 573 | $80K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 6.1% | 1,297 | 677 | $72K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.4% | 2,782 | 1,781 | $41K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 454 | 227 | $23K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.6% | 709 | 586 | $18K |
| 90836 | 1.5% | 836 | 514 | $18K | |
| H0049 | Alcohol and/or drug screening | 1.4% | 836 | 531 | $16K |
12 more codes
| 99213 | Doctor's office visit, returning patient (routine) | 1.1% | 756 | $13K |
| 80305 | <1% | 3,108 | $11K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 481 | $6K |
| 99205 | Prolong outpt/office vis | <1% | 72 | $5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 404 | $3K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 168 | $3K |
| 99408 | <1% | 109 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 25 | $2K |
| 93040 | <1% | 40 | $169.68 | |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | <1% | 17 | $137.70 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 44 | $92.63 |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 37 | $64.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAMPION, DARRYL (ADMINISTRATOR)